Migraine aura

Neurologist

Volumn 13, Issue 3, 2007, Pages 118-125

  Cutrer, F Michael ^a   Huerter, Karina ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aura; Clinical features; Genetics; Migraine; Pathophysiology; Scotoma

Indexed keywords

ACETAZOLAMIDE; AMYL NITRATE; FUROSEMIDE; ISOPRENALINE; KETAMINE; LAMOTRIGINE; MAGNESIUM SULFATE; NIFEDIPINE; PLACEBO; PROCHLORPERAZINE; VALPROATE SEMISODIUM;

BRAIN CORTEX; CLINICAL TRIAL; DISEASE CLASSIFICATION; HEADACHE; HEREDITY; HUMAN; MIGRAINE AURA; NEUROIMAGING; NEUROPATHOLOGY; NOCICEPTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPREADING CORTICAL DEPRESSION; SYMPTOM; TRIGEMINAL NERVE; UNITED STATES;

HUMANS; MIGRAINE WITH AURA;

EID: 34248347032     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000252943.82792.38     Document Type: Review

References (73)

1. Headache Classification Subcommittee of the International Headache Society. International classification of headache disorders: ed 2. Cephalalgia, 2004;24(suppl 1):25-36.
2. Rasmussen BE, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12:221-228.
3. Nikiforow R. Headache in a random sample of 200 persons: a clinical study of a population in Northern Finland. Cephalalgia. 1981;1:99-107.
4. Merikangas KA, Angst J, Ishler H. Migraine and psychopathology. Arch Gen Psychiatry. 1990;47:849-853.
5. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorder, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37:11-23.
6. Russell MB, Rasmussen BK, Thorvaldsen P, et al. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24:612-618.
7. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119:335-361.
8. Horev A, Wirguin I, Lantsberg L, et al. A high incidence of migraine with aura among morbidly obese women. Headache. 2005;45:936-938.
9. Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;134:1111-1120.
10. Ziegler DK, Hassanein RS. Specific headache phenomena: their frequency and coincidence. Headache. 1990;30:152-156.
11. Manzoni GC, Farina S, Lanfranchi M, et al. Classic migraine: clinical findings in 164 patients. Eur Neurol. 1985;24:163-169.
12. Eriksen MK, Thomsen LL, Andersen I, et al. Clinical characteristics of 362 patient with familial migraine with aura. Cephalalgia. 2004;24:564-575.
13. Bana DS, Graham JR. Observations on prodromes of classic migraine in a headache population. Headache. 1986;26:216-219.
14. Russell MB, Iversen HK, Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia. 1994;14:107-117.
15. Schiller F. The migraine tradition. Bull Hist Med. 1975;49:1-19.
16. Airy H. On a distinct form of transient hemiopsia. Philos Trans R Soc Lond B Biol Sci. 1870;160:247-264.
17. Jolly F. Über Flimmerskotom und Migraene. Berlin Klin Wschr. 1902;42:973-976.
18. Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry. 1941;46:259-264.
19. Fisher CM. Late-life migraine accompaniments: further experience. Stroke. 1986;17:1033-1042.
20. Lord GDA. Clinical characteristics of the migrainous aura. In: Amery WK, Wauquier A, eds. The Prelude to the Migraine Attack. London: Baillière Tindall; 1986:87-98.
21. Bradshaw P, Parsons M. Hemiplegic migraine: a clinical study. Q J Med. 1965;34:65-85.
22. Wolff HG. Headache and Other Head Pain. 2nd ed. New York: Oxford University Press; 1963.
23. Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359-390.
24. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344-352.
25. Lauritzen M, Skyhoj Olsen T, Lassen NA, et al. Changes of regional cerebral blood flow during the course of classical migraine attacks. Ann Neurol. 1983;13:633-641.
26. Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography. Brain. 1984;107:447-461.
27. Skyhoj Olsen T, Friberg L, Lassen NA. Ischemia may be the primary cause of neurologic deficits in classical migraine. Arch Neurol. 1987;44:156-161.
28. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689-1692.
29. Olesen J. Understanding the biologic basis of migraine. N Engl J Med. 1994;331:1713-1714.
30. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658-660.
31. Sanchez del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia. 1999;19:1-17.
32. Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998;43:25-31.
33. Sorensen AG, Rosen BR. Functional MRI of the brain. In: Atlas S, ed. Magnetic Resonance Imaging of the Brain and Spine. 2nd ed. Philadelphia: Lippcott-Raven Publishers; 1996.
34. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;10:4687-4692.
35. James MF, Smith MI, Bockhorst KH, et al. Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging. J Physiol. 1999;519(pt 2):415-425.
36. Cao Y, Aurora SK, Nagesh V, et al. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology. 2002;59:72-78.
37. Jager HR, Giffin NJ, Goadsby PJ. Diffusion and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia. 2005;25:323-332.
38. Smith M, Cros D, Sheen V. Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology. 2002;58:1308-1310.
39. Gekeler F, Holtmannspotter M, Straube A, et al. Diffusion-weighted magnetic resonance imaging during the aura of pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis. Headache. 2002;42:294-296.
40. Relja G, Granato A, Ukmar M, et al. Persistent aura without infarction: description of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia. 2005;25:56-59.
41. Welch KMA, Levine SR, D'Andrea G, et al. Brain pH during migraine studied by in-vivo 31-phosphorus NMR spectroscopy. Cephalalgia. 1988;8:273-277.
42. Welch KMA, Levine SR, D'Andrea G, et al. Preliminary observations on brain energy metabolites in migraine studied by in vivo 31-phosphorus NMR spectroscopy. Neurology. 1989;39:538-541.
43. Welch KMA, Barkley GL, Ramadan NM, et al. NMR spectroscopic and magnetoencephalographic studies in migraine with aura: support for the spreading depression hypothesis. Pathol Biol. 1992;40:349-354.
44. van Harreveld A, Fifekova E. Mechanisms involved in spreading depression. J Neurobiol. 1973;4:375-387.
45. Sandor PS, Dydak U, Schoenen J, et al. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia. 2005;25:507-518.
46. Ambrosini A, de Noordhout AM, Sandor PS, et al. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia. 2003;23(suppl 1):13-31.
47. Aurora SK, Welch KM, Al-Sayed F. The threshold for phosphenes is lower in migraine. Cephalalgia. 2003;23:258-263.
48. Kara I, Sazci A, Ergul E, et al. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003;17:84-90.
49. Wessman M, Kallela M, Kaunisto MA, et al.Asusceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet. 2002;70:652-662.
50. Carlsson A, Forsgren L, Nylander PO, et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology. 2002;59:1804-1807.
51. Cader ZM, Noble-Topham S, Dyment DA, et al. Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet. 2003;12:2511-2617.
52. Russo L, Mariotti P, Sangiorgi E, et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet. 2005;76:327-333.
53. Kowa H, Fusayasu E, Ijiri T, et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett. 2005;374:129-131.
54. Racchi M, Leone M, Porrello E, et al. Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms. Headache. 2004;44:311-317.
55. Marziniak M, Mossner R, Schmitt A, et al. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology. 2005;64:157-159.
56. Lea RA, Nyholt DR, Curtain RP, et al. A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics. 2005;6:67-72.
57. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993;13:1167-1177.
58. Kraig RP, Nicholson C. Extracellular ionic variations during spreading depression. Neuroscience. 1978;3:1045-1059.
59. Obrenovitch TP, Urenjak J, Wang M. Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow Metab. 2002;22:680-688.
60. Lauritzen M, Hansen AJ, Kronborg D, et al. Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge. J Cereb Blood Flow Metab. 1990;10:115-122.
61. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004;113:1447-1455.
62. Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8:136-142.
63. Pascual J, Caminero AB, Mateos V, et al. Preventing disturbing migraine aura with lamotrigine: an open study. Headache. 2004;44:1024-1028.
64. Steiner TJ, Findley LJ, Yuen AW. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia. 1997;17:109-112.
65. Lampl C, Katsarava Z, Diener HC, et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:1730-1732.
66. Kaube H, Herzog J, Kaufer T, et al. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55:139-141.
67. Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology. 1997;48:261-262.
68. Forteza AM, Brozman B, Rabinstein AA, et al. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology. 2001;57:2144-2145.
69. Dalessio DJ, ed. Wolff's Headache and Other Head Pain. 4th ed. Oxford: Oxford University Press; 1980.
70. Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke. 1987;27:484-486.
71. Goldner JA, Levitt LP. Treatment of complicated migraine with sublingual nifedipine. Headache. 1987;27:484-486.
72. Rozen TD. Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate. Headache. 2003;43:901-903.
73. Rozen TD. Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology. 2000;55:732-733.